certolizumab pegol psoriasis
Selected indexed studies
- Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy. (Skin Therapy Lett, 2021) [PMID:33769772]
- Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis. (BioDrugs, 2020) [PMID:32207094]
- Summary of certolizumab pegol in psoriasis including structural features, pharmacokinetics and treatment. (Immunotherapy, 2024) [PMID:38319071]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis. (2020) pubmed
- Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy. (2021) pubmed
- Summary of certolizumab pegol in psoriasis including structural features, pharmacokinetics and treatment. (2024) pubmed
- Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis. (2020) pubmed
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. (2019) pubmed
- Biologics for Psoriasis. (2024) pubmed
- Certolizumab pegol for the treatment of psoriasis. (2017) pubmed
- PMID:40902025 (2019) pubmed
- New Treatment Addressing the Pathogenesis of Psoriasis. (2020) pubmed
- Certolizumab pegol in the treatment of psoriasis: Real-life data. (2021) pubmed